Brigham and Women's Hospital: A Teaching Affiliate of Harvard Medical School
TEXT SIZE: Increase Font Size / Decrease Font Size
Icon PrintPRINT
En EspanolESPAÑOL
Bookmark and Share
FIND A DOCTOR
REQUEST AN APPOINTMENT
  •  
  •  
    • History and Description
    • Locations and Directions
    • Innovative Care
    • News
    • Quality of Patient Care
    • Visiting BWH
    • Giving to BWH
    • Departments and Services
    • Contact Us
    • Careers
  •  

      CLINICAL DEPARTMENTS


    • Anesthesia
    • Cancer
    • Dermatology
    • Emergency Medicine
    • Medicine
    • Neurology
    • Neurosurgery
    • Newborn Medicine
    • Obstetrics and Gynecology
    • Orthopedic Surgery
    • Pathology
    • Psychiatry
    • Radiation Oncology
    • Radiology
    • Surgery
    • A to Z Listing of All Departments/Services

    • CENTERS OF EXCELLENCE


    • Cancer
    • Cardiovascular
    • Orthopedic and Arthritis
    • Neurosciences
    • Women's Health

      PATIENT CARE SERVICES


    • Care Coordination/ Social Work
    • Chaplaincy
    • Interpreter Services
    • Nursing
    • Nutrition
    • Patient and Family Relations
    • All Patient Care Services

  • Browse by Letter

    a
    b
    c
    d
    e
    f
    g
    h
    i
    j
    k
    l
    m
    n
    o
    p
    q
    r
    s
    t
    u
    v
    w
    x
    y
    z

    Specialty Areas

    • CANCER
    • HEART DISEASE
    • ORTHOPEDIC CONDITIONS
    • WOMEN'S HEALTH

    Search for Diseases
    and Conditions



  •  
    • Adult Health Library
    • En Español
    • Health Information Center
    • Interactive Tools and Media
    • Health News
    • Health Events
    • Health Publications
    • Video Center
    • BWH Kessler Library


  •  
    • Find a Doctor
    • Request an Appointment
    • Locations and Directions
    • Phone Numbers
    • Your Hospital Visit
    • Accessibility
    • Quality of Patient Care
    • Patient Gateway
    • Patient Resources
    • International Patients
    • Visitors


  •  

      RESEARCH AT BWH


    • About Research at BWH
    • BRI Centers and Programs
    • Find a Researcher
    • BRIefs
    • Departments
    • Laboratories and Research Projects
    • Research: Clinical

    • GET INVOLVED


    • Clinical Trials
    • Volunteer Opportunities

      FOR BWH RESEARCHERS


    • Biomedical Research Institute
    • Center for Clinical Investigation
    • Center for Faculty Development and Diversity
    • Cores and Resources
    • Office for Research Careers
    • Research Administration
    • Research Ventures and Licensing
  •  
    • Referring a Patient
    • Our Commitment to Quality
    • Educational Resources
    • Medical Community Events
    • BWH Residencies and Fellowships
    • Department of Nursing
    • Center for Nursing Excellence
    • Center for Faculty Development and Diversity
    • Center for Professionalism and Peer Support
Find A Researcher
  Previous  |  New Search  |  Return to Search Results  |  Next  

Karen H. Costenbader, MD, MPH


  View Physician Profile

Rheumatologist, Brigham and Women's Hospital
Associate Professor of Medicine, Harvard Medical School

Brigham and Women's Hospital
Department of Medicine
Rheumatology, Immunology
75 Francis Street
Boston, MA 02115

Research Location: Boston Lying-In



Research Narrative:

Our research is focused on epidemiology and outcomes of rheumatic diseases, in particular Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE).  Our group has developed innovative epidemiologic tools for testing hypotheses in populations, investigated the epidemiology of rheumatic diseases in large cohorts of female health professionals, studied predictors of outcome in RA and SLE and established a large SLE Registry.  

In recent work, our group has studied associations between cigarette smoking and RA and SLE, postmenopausal hormones and oral contraceptive use and risk of SLE, antioxidants and vitamin D intake and the risks of RA and SLE. We are investigating novel biomarkers and causal pathways in the development of RA. Our group also studies predictors of outcomes, including cardiovascular disease, lymphoma, nephritis and end-stage renal disease, among patients with SLE, and sociodemographic disparities in the incidence and outcomes of SLE in the U.S.. The BWH Lupus Registryincludes >1700 SLE patients from BWH and the BWH Lupus Biobank, housed at the Broad Institute, contains stored samples on many of this cohort. We are currently investigating biomarkers of SLE activity and disease risk, whether high dose vitamin D and/or fish oil intake are effective in the prevention of autoimmune disease, and access to care and outcomes among patients with SLE.

 
Education: Harvard School of Public Health, 2002, MPH
Harvard Medical School, 1995, MD
Cambridge University, 1991, MA
 
Honors/Awards: Mary Betty Stevens Young Investigator, Lupus Foundation of America, 2009
Henry Kunkel Young Investigator, American College of Rheumatology,2011
 
Lab Members: Elizabeth Arkema, MPH
Joseph Merola, MD
Linda Hiraki, MD, MPH
Candace Feldman, MD, MPH
Jose Gomez Puerta, MD, PhD
Sara Tedeschi, MD
 
Collaborators: Immaculata DeVivo, PhD, HSPH

JoAnn Manson, MD, DrPH, BWH

Daniel Solomon, MD, MPH, BWH

Elizabeth Karlson, MD, BWH

Elena Massarotti, MD, BWH

Wolfgang Winkelmayer, MD, ScD, Stanford University

Peter Schur, MD, BWH

Bonnie Bermas, MD, BWH

I-Min Lee, MD, MPH, BWH

George Tsokos, MD, PhD, BIDMC

 
Keywords (MeSH): Autoantibodies
Antirheumatic Agents
Peptides, Cyclic
Protein Tyrosine Phosphatase, Non-Receptor Type 22
Lupus Erythematosus, Systemic
Arthritis, Rheumatoid
Lupus Nephritis
Rheumatic Diseases
Smoking
 
Link to PubMed: View Costenbader's Publications in PubMed.
 

Publications (Pulled from Harvard Catalyst Profiles):

1. Feldman CH, Hiraki LT, Liu J, Fischer MA, Solomon DH, Alarcón GS, Winkelmayer WC, Costenbader KH. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013 Mar; 65(3):753-63.

2. Hiraki LT, Munger KL, Costenbader KH, Karlson EW. Reply. Arthritis Care Res (Hoboken). 2013 Mar; 65(3):491-2.

3. Arkema EV, Hart JE, Bertrand KA, Laden F, Grodstein F, Rosner BA, Karlson EW, Costenbader KH. Exposure to ultraviolet-B and risk of developing rheumatoid arthritis among women in the Nurses' Health Study. Ann Rheum Dis. 2013 Apr; 72(4):506-11.

4. Hiraki LT, Munger KL, Costenbader KH, Karlson EW. Dietary intake of vitamin D during adolescence and risk of adult-onset systemic lupus erythematosus and rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012 Dec; 64(12):1829-36.

5. Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Reply. Arthritis Care Res (Hoboken). 2012 Nov; 64(11):1785-6.

6. Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH. Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum. 2012 Aug; 64(8):2669-76.

7. Hart JE, Källberg H, Laden F, Bellander T, Costenbader KH, Holmqvist M, Klareskog L, Alfredsson L, Karlson EW. Ambient air pollution exposures and risk of rheumatoid arthritis: results from the Swedish EIRA case-control study. Ann Rheum Dis. 2012 Jul 24.

8. Miller FW, Alfredsson L, Costenbader KH, Kamen DL, Nelson LM, Norris JM, De Roos AJ. Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences Expert Panel Workshop. J Autoimmun. 2012 Dec; 39(4):259-71.

9. Clowse ME, Chakravarty E, Costenbader KH, Chambers C, Michaud K. Effects of infertility, pregnancy loss, and patient concerns on family size of women with rheumatoid arthritis and systemic lupus erythematosus. Arthritis Care Res (Hoboken). 2012 May; 64(5):668-74.

10. Devlin A, Waikar SS, Solomon DH, Lu B, Shaykevich T, Alarcón GS, Winkelmayer WC, Costenbader KH. Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.

show all
11. Costenbader KH, Gay S, Alarcón-Riquelme ME, Iaccarino L, Doria A. Genes, epigenetic regulation and environmental factors: which is the most relevant in developing autoimmune diseases? Autoimmun Rev. 2012 Jun; 11(8):604-9.

12. Goldstein BL, Chibnik LB, Karlson EW, Costenbader KH. Epstein-Barr virus serologic abnormalities and risk of rheumatoid arthritis among women. Autoimmunity. 2012 Mar; 45(2):161-8.

13. Chibnik LB, Keenan BT, Cui J, Liao KP, Costenbader KH, Plenge RM, Karlson EW. Genetic risk score predicting risk of rheumatoid arthritis phenotypes and age of symptom onset. PLoS One. 2011; 6(9):e24380.

14. Hiraki LT, Lu B, Alexander SR, Shaykevich T, Alarcón GS, Solomon DH, Winkelmayer WC, Costenbader KH. End-stage renal disease due to lupus nephritis among children in the US, 1995-2006. Arthritis Rheum. 2011 Jul; 63(7):1988-97.

15. Bengtsson C, Bengtsson A, Costenbader Kh, Jönsen A, Rantapää-Dahlqvist S, Sturfelt G, Nived O. Systemic lupus erythematosus and cardiac risk factors: medical record documentation and patient adherence. Lupus. 2011 Oct; 20(10):1057-62.

16. Costenbader KH. Rheumatic disease research and implications for clinical care. Int J Clin Pract. 2011 Jun; 65(6):637-8.

17. Costenbader KH, Desai A, Alarcón GS, Hiraki LT, Shaykevich T, Brookhart MA, Massarotti E, Lu B, Solomon DH, Winkelmayer WC. Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.

18. Costenbader KH, Prescott J, Zee RY, De Vivo I. Immunosenescence and rheumatoid arthritis: does telomere shortening predict impending disease? Autoimmun Rev. 2011 Jul; 10(9):569-73.

19. Costenbader KH, Solomon DH. Entering a new era of prevention in rheumatic disease. Curr Opin Rheumatol. 2011 Mar; 23(2):178.

20. Costenbader K, Laden F. What do pesticides, farming, and dose effects have to do with the risk of developing connective tissue disease? Arthritis Care Res (Hoboken). 2011 Feb; 63(2):175-7.

21. Lu B, Solomon DH, Costenbader KH, Keenan BT, Chibnik LB, Karlson EW. Alcohol consumption and markers of inflammation in women with preclinical rheumatoid arthritis. Arthritis Rheum. 2010 Dec; 62(12):3554-9.

22. Kriegel MA, Manson JE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease?: a systematic review. Semin Arthritis Rheum. 2011 Jun; 40(6):512-531.e8.

23. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2010 Sep; 62(9):2569-81.

24. Neogi T, Aletaha D, Silman AJ, Naden RL, Felson DT, Aggarwal R, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Khanna D, Kvien TK, Laing T, Liao K, Mease P, Ménard HA, Moreland LW, Nair R, Pincus T, Ringold S, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovský J, Wolfe F, Hawker G. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report. Arthritis Rheum. 2010 Sep; 62(9):2582-91.

25. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD, Combe B, Costenbader KH, Dougados M, Emery P, Ferraccioli G, Hazes JM, Hobbs K, Huizinga TW, Kavanaugh A, Kay J, Kvien TK, Laing T, Mease P, Ménard HA, Moreland LW, Naden RL, Pincus T, Smolen JS, Stanislawska-Biernat E, Symmons D, Tak PP, Upchurch KS, Vencovsky J, Wolfe F, Hawker G. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010 Sep; 69(9):1580-8.

26. Arkema EV, Karlson EW, Costenbader KH. A prospective study of periodontal disease and risk of rheumatoid arthritis. J Rheumatol. 2010 Sep; 37(9):1800-4.

27. Costenbader KH, Kang JH, Karlson EW. Antioxidant intake and risks of rheumatoid arthritis and systemic lupus erythematosus in women. Am J Epidemiol. 2010 Jul 15; 172(2):205-16.

28. Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, Li Y, Kurreeman FA, Zhernakova A, Hinks A, Guiducci C, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Brouwer E, Burtt NP, Catanese JJ, Coblyn J, Coenen MJ, Costenbader KH, Criswell LA, Crusius JB, Cui J, de Bakker PI, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TW, Kastner DL, Ke X, Lee AT, Liu X, Martin P, Morgan AW, Padyukov L, Posthumus MD, Radstake TR, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AH, van der Horst-Bruinsma IE, van der Schoot CE, van Riel PL, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth BP, Wijmenga C, Karlson EW, Toes RE, de Vries N, Begovich AB, Worthington J, Siminovitch KA, Gregersen PK, Klareskog L, Plenge RM. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010 Jun; 42(6):508-14.

29. Crispín JC, Keenan BT, Finnell MD, Bermas BL, Schur P, Massarotti E, Karlson EW, Fitzgerald LM, Ergin S, Kyttaris VC, Tsokos GC, Costenbader KH. Expression of CD44 variant isoforms CD44v3 and CD44v6 is increased on T cells from patients with systemic lupus erythematosus and is correlated with disease activity. Arthritis Rheum. 2010 May; 62(5):1431-7.

30. Demas KL, Keenan BT, Solomon DH, Yazdany J, Costenbader KH. Osteoporosis and cardiovascular disease care in systemic lupus erythematosus according to new quality indicators. Semin Arthritis Rheum. 2010 Dec; 40(3):193-200.

31. Costenbader KH, Khamashta M, Ruiz-Garcia S, Perez-Rodriguez MT, Petri M, Elliott J, Manzi S, Karlson EW, Turner-Stokes T, Bermas B, Coblyn J, Massarotti E, Schur P, Fraser P, Navarro I, Hanly JG, Shaver TS, Katz RS, Chakravarty E, Fortin PR, Sanchez ML, Liu J, Michaud K, Alarcón GS, Wolfe F. Development and initial validation of a self-assessed lupus organ damage instrument. Arthritis Care Res (Hoboken). 2010 Apr; 62(4):559-68.

32. Vieira VM, Hart JE, Webster TF, Weinberg J, Puett R, Laden F, Costenbader KH, Karlson EW. Association between residences in U.S. northern latitudes and rheumatoid arthritis: A spatial analysis of the Nurses' Health Study. Environ Health Perspect. 2010 Jul; 118(7):957-61.

33. Chibnik LB, Massarotti EM, Costenbader KH. Identification and validation of lupus nephritis cases using administrative data. Lupus. 2010 May; 19(6):741-3.

34. Karlson EW, Costenbader KH. Epidemiology: Interpreting studies of interactions between RA risk factors. Nat Rev Rheumatol. 2010 Feb; 6(2):72-3.

35. Karlson EW, Chang SC, Cui J, Chibnik LB, Fraser PA, De Vivo I, Costenbader KH. Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis. 2010 Jan; 69(1):54-60.

36. Liao KP, Costenbader KH. Getting them even earlier: Identifying individuals before clinical presentation with rheumatoid arthritis. Arthritis Rheum. 2009 Dec 15; 61(12):1620-2.

37. Aggarwal R, Liao K, Nair R, Ringold S, Costenbader KH. Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis. Arthritis Rheum. 2009 Nov 15; 61(11):1472-83.

38. Raychaudhuri S, Thomson BP, Remmers EF, Eyre S, Hinks A, Guiducci C, Catanese JJ, Xie G, Stahl EA, Chen R, Alfredsson L, Amos CI, Ardlie KG, Barton A, Bowes J, Burtt NP, Chang M, Coblyn J, Costenbader KH, Criswell LA, Crusius JB, Cui J, De Jager PL, Ding B, Emery P, Flynn E, Harrison P, Hocking LJ, Huizinga TW, Kastner DL, Ke X, Kurreeman FA, Lee AT, Liu X, Li Y, Martin P, Morgan AW, Padyukov L, Reid DM, Seielstad M, Seldin MF, Shadick NA, Steer S, Tak PP, Thomson W, van der Helm-van Mil AH, van der Horst-Bruinsma IE, Weinblatt ME, Wilson AG, Wolbink GJ, Wordsworth P, Altshuler D, Karlson EW, Toes RE, de Vries N, Begovich AB, Siminovitch KA, Worthington J, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Genetic variants at CD28, PRDM1 and CD2/CD58 are associated with rheumatoid arthritis risk. Nat Genet. 2009 Dec; 41(12):1313-8.

39. Hak AE, Karlson EW, Feskanich D, Stampfer MJ, Costenbader KH. Systemic lupus erythematosus and the risk of cardiovascular disease: results from the nurses' health study. Arthritis Rheum. 2009 Oct 15; 61(10):1396-402.

40. Simard JF, Costenbader KH, Hernán MA, Liang MH, Mittleman MA, Karlson EW. Early life factors and adult-onset rheumatoid arthritis. J Rheumatol. 2010 Jan; 37(1):32-7.

41. Pons-Estel BA, Sánchez-Guerrero J, Romero-Díaz J, Iglesias-Gamarra A, Bonfa E, Borba EF, Shinjo SK, Bernatsky S, Clarke A, García MA, Marcos JC, Duarte A, Berbotto GA, Scherbarth H, Marques CD, Onetti L, Saurit V, Souza AW, Velozo E, Catoggio LJ, Neira O, Burgos PI, Ramirez LA, Molina JF, De La Torre IG, Silvariño R, Manni JA, Durán-Barragán S, Vilá LM, Fortin PR, Calvo-Alén J, Santos MJ, Portela M, Esteva-Spinetti MH, Weisman M, Acevedo EM, Segami MI, Gentiletti SB, Roldán J, Navarro I, Gonzalez E, Liu JM, Karlson EW, Costenbader KH, Wolfe F, Alarcón GS. Validation of the Spanish, Portuguese and French versions of the Lupus Damage Index questionnaire: data from North and South America, Spain and Portugal. Lupus. 2009 Oct; 18(12):1033-52.

42. Todd DJ, Costenbader KH. Dyspnoea in a young woman with active systemic lupus erythematosus. Lupus. 2009 Aug; 18(9):777-84.

43. Karlson EW, Chibnik LB, McGrath M, Chang SC, Keenan BT, Costenbader KH, Fraser PA, Tworoger S, Hankinson SE, Lee IM, Buring J, De Vivo I. A prospective study of androgen levels, hormone-related genes and risk of rheumatoid arthritis. Arthritis Res Ther. 2009; 11(3):R97.

44. Lee YC, Raychaudhuri S, Cui J, De Vivo I, Ding B, Alfredsson L, Padyukov L, Costenbader KH, Seielstad M, Graham RR, Klareskog L, Gregersen PK, Plenge RM, Karlson EW. The PRL -1149 G/T polymorphism and rheumatoid arthritis susceptibility. Arthritis Rheum. 2009 May; 60(5):1250-4.

45. Simard JF, Costenbader KH, Liang MH, Karlson EW, Mittleman MA. Exposure to maternal smoking and incident SLE in a prospective cohort study. Lupus. 2009 Apr; 18(5):431-5.

46. Hart JE, Laden F, Puett RC, Costenbader KH, Karlson EW. Exposure to traffic pollution and increased risk of rheumatoid arthritis. Environ Health Perspect. 2009 Jul; 117(7):1065-9.

47. Karlson EW, Chibnik LB, Tworoger SS, Lee IM, Buring JE, Shadick NA, Manson JE, Costenbader KH. Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies. Arthritis Rheum. 2009 Mar; 60(3):641-52.

48. Liang MH, Simard JF, Costenbader K, Dore BT, Ward M, Fortin PR, Illei GG, Manzi S, Mittleman B, Buyon J, Gupta S, Abrahamowicz M. Methodologic issues in the validation of putative biomarkers and surrogate endpoints in treatment evaluation for systemic lupus erythematosus. Endocr Metab Immune Disord Drug Targets. 2009 Mar; 9(1):108-12.

49. Demas KL, Costenbader KH. Disparities in lupus care and outcomes. Curr Opin Rheumatol. 2009 Mar; 21(2):102-9.

50. Aizer J, Karlson EW, Chibnik LB, Costenbader KH, Post D, Liang MH, Gall V, Gerhard-Herman MD. A controlled comparison of brachial artery flow mediated dilation (FMD) and digital pulse amplitude tonometry (PAT) in the assessment of endothelial function in systemic lupus erythematosus. Lupus. 2009 Mar; 18(3):235-42.

51. Wesemann DR, Costenbader KH, Coblyn JS. Co-existing sarcoidosis, systemic lupus erythematosus and the antiphospholipid antibody syndrome: case reports and discussion from the Brigham and Women's Hospital Lupus Center. Lupus. 2009 Mar; 18(3):202-5.

52. Chibnik LB, Mandl LA, Costenbader KH, Schur PH, Karlson EW. Comparison of threshold cutpoints and continuous measures of anti-cyclic citrullinated peptide antibodies in predicting future rheumatoid arthritis. J Rheumatol. 2009 Apr; 36(4):706-11.

53. Lee YC, Cui J, Costenbader KH, Shadick NA, Weinblatt ME, Karlson EW. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Rheumatology (Oxford). 2009 Jun; 48(6):613-7.

54. Raychaudhuri S, Remmers EF, Lee AT, Hackett R, Guiducci C, Burtt NP, Gianniny L, Korman BD, Padyukov L, Kurreeman FA, Chang M, Catanese JJ, Ding B, Wong S, van der Helm-van Mil AH, Neale BM, Coblyn J, Cui J, Tak PP, Wolbink GJ, Crusius JB, van der Horst-Bruinsma IE, Criswell LA, Amos CI, Seldin MF, Kastner DL, Ardlie KG, Alfredsson L, Costenbader KH, Altshuler D, Huizinga TW, Shadick NA, Weinblatt ME, de Vries N, Worthington J, Seielstad M, Toes RE, Karlson EW, Begovich AB, Klareskog L, Gregersen PK, Daly MJ, Plenge RM. Common variants at CD40 and other loci confer risk of rheumatoid arthritis. Nat Genet. 2008 Oct; 40(10):1216-23.

55. Simard JF, Karlson EW, Costenbader KH, Hernán MA, Stampfer MJ, Liang MH, Mittleman MA. Perinatal factors and adult-onset lupus. Arthritis Rheum. 2008 Aug 15; 59(8):1155-61.

56. Costenbader KH, Chang SC, Laden F, Puett R, Karlson EW. Geographic variation in rheumatoid arthritis incidence among women in the United States. Arch Intern Med. 2008 Aug 11; 168(15):1664-70.

57. Mandl LA, Costenbader KH, Simard JF, Karlson EW. Is birthweight associated with risk of rheumatoid arthritis? Data from a large cohort study. Ann Rheum Dis. 2009 Apr; 68(4):514-8.

58. Kyttaris VC, Costenbader KH. Whole genome association study results shed light on elusive aetiopathogenesis of systemic lupus erythematosus. Int J Clin Pract. 2008 Jun; 62(6):852-4.

59. Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene-environment interactions with heavy cigarette smoking. Arthritis Res Ther. 2008; 10(3):R52.

60. Lee DM, Phillips R, Hagan EM, Chibnik LB, Costenbader KH, Schur PH. Quantifying anti-cyclic citrullinated peptide titres: clinical utility and association with tobacco exposure in patients with rheumatoid arthritis. Ann Rheum Dis. 2009 Feb; 68(2):201-8.

61. Costenbader KH, Manson JE. Do female hormones affect the onset or severity of rheumatoid arthritis? Arthritis Rheum. 2008 Mar 15; 59(3):299-301.

62. Rosenau BJ, Costenbader KH, Schur PH. C-reactive protein, anti-C-reactive protein antibodies and clinical atherosclerosis. Vasc Med. 2008 Feb; 13(1):25-8.

63. Liao KP, Batra KL, Chibnik L, Schur PH, Costenbader KH. Anti-cyclic citrullinated peptide revised criteria for the classification of rheumatoid arthritis. Ann Rheum Dis. 2008 Nov; 67(11):1557-61.

64. Costenbader KH, Chibnik LB, Schur PH. Discordance between erythrocyte sedimentation rate and C-reactive protein measurements: clinical significance. Clin Exp Rheumatol. 2007 Sep-Oct; 25(5):746-9.

65. Costenbader KH, Feskanich D, Holmes M, Karlson EW, Benito-Garcia E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann Rheum Dis. 2008 Apr; 67(4):530-5.

66. Simard JF, Costenbader KH. What can epidemiology tell us about systemic lupus erythematosus? Int J Clin Pract. 2007 Jul; 61(7):1170-80.

67. Costenbader KH, Kountz DS. Treatment and management of early RA: A primary care primer. J Fam Pract. 2007 Jul; 56(7 Suppl):S1-7; quiz S8.

68. Costenbader KH, Liang MH, Chibnik LB, Aizer J, Kwon H, Gall V, Karlson EW. A pravastatin dose-escalation study in systemic lupus erythematosus. Rheumatol Int. 2007 Sep; 27(11):1071-7.

69. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum. 2007 Apr; 56(4):1251-62.

70. Todd DJ, Costenbader KH, Weinblatt ME. Abatacept in the treatment of rheumatoid arthritis. Int J Clin Pract. 2007 Mar; 61(3):494-500.

71. Costenbader KH, Brome D, Blanch D, Gall V, Karlson E, Liang MH. Factors determining participation in prevention trials among systemic lupus erythematosus patients: a qualitative study. Arthritis Rheum. 2007 Feb 15; 57(1):49-55.

72. King JK, Costenbader KH. Characteristics of patients with systemic lupus erythematosus (SLE) and non-Hodgkin's lymphoma (NHL). Clin Rheumatol. 2007 Sep; 26(9):1491-4.

73. Finckh A, Dehler S, Costenbader KH, Gabay C. Cigarette smoking and radiographic progression in rheumatoid arthritis. Ann Rheum Dis. 2007 Aug; 66(8):1066-71.

74. Karlson EW, Watts J, Signorovitch J, Bonetti M, Wright E, Cooper GS, McAlindon TE, Costenbader KH, Massarotti EM, Fitzgerald LM, Jajoo R, Husni ME, Fossel AH, Pankey H, Ding WZ, Knorr R, Condon S, Fraser PA. Effect of glutathione S-transferase polymorphisms and proximity to hazardous waste sites on time to systemic lupus erythematosus diagnosis: results from the Roxbury lupus project. Arthritis Rheum. 2007 Jan; 56(1):244-54.

75. Costenbader KH, Glass R, Cui J, Shadick N. Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis. JAMA. 2006 Nov 8; 296(18):2201; author reply 2203-4.

76. Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, Fraser PA, Karlson EW. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum. 2006 Nov; 54(11):3648-54.

77. Costenbader KH, Fidias P, Gilman MD, Qureshi A, Tambouret RH. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 29-2006. A 43-year-old woman with painful nodules on the fingertips, shortness of breath, and fatigue. N Engl J Med. 2006 Sep 21; 355(12):1263-72.

78. Costenbader KH, Feskanich D, Mandl LA, Karlson EW. Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women. Am J Med. 2006 Jun; 119(6):503.e1-9.

79. Costenbader KH, Karlson EW. Epstein-Barr virus and rheumatoid arthritis: is there a link? Arthritis Res Ther. 2006; 8(1):204.

80. Costenbader KH, Karlson EW. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus. 2006; 15(11):737-45.

81. Costenbader KH, Karlson EW. Cigarette smoking and systemic lupus erythematosus: a smoking gun? Autoimmunity. 2005 Nov; 38(7):541-7.

82. Costenbader KH, Karlson EW, Gall V, de Pablo P, Finckh A, Lynch M, Bermas B, Schur PH, Liang MH. Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus. Arthritis Rheum. 2005 Oct 15; 53(5):718-23.

83. Katz JN, Costenbader K, Solomon DH, Losina E. Does practice make perfect? Arthritis Rheum. 2005 Jun; 52(6):1628-31.

84. Costenbader KH, Coblyn JS. Statin therapy in rheumatoid arthritis. South Med J. 2005 May; 98(5):534-40; quiz 541, 572.

85. Karlson EW, Costenbader KH, McAlindon TE, Massarotti EM, Fitzgerald LM, Jajoo R, Husni E, Wright EA, Pankey H, Fraser PA. High sensitivity, specificity and predictive value of the Connective Tissue Disease Screening Questionnaire among urban African-American women. Lupus. 2005; 14(10):832-6.

86. Costenbader KH, Wright E, Liang MH, Karlson EW. Cardiac risk factor awareness and management in patients with systemic lupus erythematosus. Arthritis Rheum. 2004 Dec 15; 51(6):983-8.

87. Costenbader KH, Kim DJ, Peerzada J, Lockman S, Nobles-Knight D, Petri M, Karlson EW. Cigarette smoking and the risk of systemic lupus erythematosus: a meta-analysis. Arthritis Rheum. 2004 Mar; 50(3):849-57.

88. Costenbader KH, Liang MH. SLE - Practical and theoretical barriers to the prevention of accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Res Ther. 2003; 5(4):178-9.

89. Costenbader KH, Karlson EW, Mandl LA. Defining lupus cases for clinical studies: the Boston weighted criteria for the classification of systemic lupus erythematosus. J Rheumatol. 2002 Dec; 29(12):2545-50.

90. Liang MH, Mandl LA, Costenbader K, Fox E, Karlson E. Atherosclerotic vascular disease in systemic lupus erythematosus. J Natl Med Assoc. 2002 Sep; 94(9):813-9.

91. Costenbader KH, Kieval RI, Anderson RJ. Eosinophilic fasciitis presenting as pitting edema of the extremities. Am J Med. 2001 Sep; 111(4):318-20.

92. Costenbader K, Ardaillou N, Marchetti J, Placier S, Ardaillou R. Prostaglandin E2 enhances type 2-bradykinin receptor expression in human glomerular podocytes. Biochim Biophys Acta. 1997 Sep 11; 1358(2):142-52.

93. Ardaillou N, Blaise V, Costenbader K, Vassitch Y, Ardaillou R. Characterization of a B2-bradykinin receptor in human glomerular podocytes. Am J Physiol. 1996 Sep; 271(3 Pt 2):F754-61.


Send Feedback to the BWH Biomedical Research Institute.

Quick Links Find a Researcher Home
EDIT YOUR PROFILE

Related Links

Department
  • View all Research Faculty in the Department of Medicine
Division
  • View all Research Faculty: Rheumatology, Immunology
BRI Research Center/Program Affiliation(s)
  • Connors-BRI Center for Women's Health and Gender Biology
  • Infectious and Immunologic Diseases Research Center
  • Musculoskeletal Research Center
  • Clinical Research Program

Laboratory and Other Research Project Website(s)
  • BWH Lupus Center


 

 

Harvard Medical School logo Partners Healthcare logo
CONTACT US DISCLAIMER DIRECTIONS GIVING PRIVACY SITE MAP
© BWH 2010 75 Francis St., Boston, MA 02115 617-732-5500